KRAS and lung carcinoma: According to the results obtained on cbx7 null MEFs, the levels of KRAS protein were found downregulated in A549 cells (human lung carcinoma line), overexpressing the CBX7 protein (Fig. 4a), in which we found higher miR-155 levels with respect to the same cells transfected with the control vector (Fig. 4b).